December 7, 2022
We have used Eculizumab in past at multiple instances and published our experience
Thereâ€™s a need to have more anti-complement drugs in Indian market. Eculizumab is costly and difficult to procure, at times when itâ€™s needed. We have used Eculizumab in past at multiple instances and published our experience. From next year, our center would be part of multinational, multicentric trial for a new subcutaneous C5 blocker Crovalimab
November 17, 2022
Happy to be part of this publication on â€˜Hemolytic Uremic Syndrome’
Happy to be part of this publication on â€˜Hemolytic Uremic Syndromeâ€™ with colleagues from Saudi Arabia and Dr Christopher Licht from Canada, which deals with how and when to discontinue Eculizumab (a very costly therapy indeed) in selected group of patients.
November 1, 2022
As you are aware that the TINKER Group (a subgroup of PCRRT-ICONIC) is working on Neonatal AKI
We recently published one of derivation & validation of STARZ neonatal AKI Risk Stratification Score. This week we publish validation of the STARZ score on group of 750 prospectively followed babies from DMC Ludhiana, Punjab, India in â€˜J Neonatal Perinatal Medicineâ€™. The link for paper is here https://pubmed.ncbi.nlm.nih.gov/36189502/
September 12, 2022
So good to meet the PCRRT-ICONIC gang finally in-person at #IPNA2022 and do healthy brain-storming !!! Love you guys!
August 24, 2022
Anti Factor H Antibodies in aHUS
Today our group has published a review on â€˜Anti Factor H Antibodies in aHUSâ€™ in â€˜Frontiers in Immunologyâ€™ today. Antibodies to Factor H is the most common cause of aHUS in children in our country and we have published multiple research papers on this in last 2 decades. Read More »
March 29, 2022
We are humbled to share that Medanta has been ranked as the Best Private Hospital in India
We are humbled to share that Medanta has been ranked as the Best Private Hospital in India by Newsweek in the World’s Best Hospitals survey for the third time in a row. Medanta is the only Indian private hospital to be listed in the Top 150 hospitals in the world. This is a testimony to
December 25, 2021
Merry X Mas to all of you and your families! Overwhelmed by greetings by kids
Hereâ€™s a x mas greeting by a child with Crescentic GN and my portrait by a recovering HUS child. May god bless them all! Wishing next year is less chaotic and peaceful for all of us !
November 13, 2021
Story of how a â€˜sad faceâ€™ Pre-transplant becomes a â€˜happy faceâ€™ after transplant!
Made by our pediatric kidney transplant recipient today on post operative day 4 in ward! Reflects how transplantation improves the QOL in ESRD.
October 21, 2021
An artist in making! A child in the ward waiting for a transplant with a â€˜to do listâ€™
An artist in making! A child in the ward waiting for a transplant with a â€˜to do listâ€™; things to be done post transplant!
November 5, 2019
The impact of fluid balance on outcomes in premature neonates: a report from the AWAKEN study group.
This study evaluated the epidemiology of fluid balance (FB) over the first postnatal week and its impact on outcomes in a multi-center cohort of premature neonates from the AWAKEN study. Positive peak Fluid balance [FB] during the first postnatal week and more positive FB on postnatal day 7 were independently associated with mechanical ventilation [MV]